FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990180269> ?p ?o ?g. }

• W2990180269 abstract "Telomere related gene (TRG) mutations are found in approximately 20% of patients with familial pulmonary fibrosis and are associated with hepatic, cutaneous and hematologic manifestations. Pirfenidone and nintedanib have been shown to slow the decline of FVC of patients with idiopathic pulmonary fibrosis (IPF). There is limited evidence of efficacy and safety of these treatments in IPF patients carrying a TRG mutation. The objective of this retrospective multicenter study was to analyze the efficacy and safety of antifibrotic drugs in IPF patients carrying a TRG mutation. We identified 103 IPF patients carrying a mutation in TERT (n=74), TERC (n=17), RTEL1 (n=10) or PARN (n=3). from 6 countries (France, Netherlands, Belgium, Spain, Greece and Switzerland) Forty-four patients received nintedanib, 59 received pirfenidone. The mean age at diagnosis was 57.9 ± 13.6 years and the median delay between diagnosis and treatment initiation was 6.0 months [3.0-15.1]. At initiation of treatment, the FVC was 80.8% ± 20.2% and the DLCO was 44.0% ± 13.7%. The median duration of treatment was 10.8 months [6.5-18.1]. Antifibrotic treatment was terminated in 18 patients because of progression of the disease and in 15 patients due to intolerable side effects, mainly digestive (nintedanib, n = 9, pirfenidone, n = 6). The median decline in FVC prior to initiation of treatment was 24.5 mL [10.5-30.1] per month. After initiation of treatment, the median decline in FVC was 18.0 mL [9.0-27.0] per month in patients treated with nintedanib and 25.4 mL per month [14.7-36.7] in patients treated with pirfenidone. This retrospective series shows that antifibrotic therapies are well tolerated in IPF patients with TRG mutations. Further analyses are needed to evaluate the efficacy." @default.
• W2990180269 created "2019-12-05" @default.
• W2990180269 creator A5014703126 @default.
• W2990180269 creator A5024611768 @default.
• W2990180269 creator A5031799252 @default.
• W2990180269 creator A5032598604 @default.
• W2990180269 creator A5034045334 @default.
• W2990180269 creator A5035168811 @default.
• W2990180269 creator A5037313446 @default.
• W2990180269 creator A5038193085 @default.
• W2990180269 creator A5038839524 @default.
• W2990180269 creator A5050803363 @default.
• W2990180269 creator A5051029267 @default.
• W2990180269 creator A5055981872 @default.
• W2990180269 creator A5057552882 @default.
• W2990180269 creator A5062488371 @default.
• W2990180269 creator A5069155913 @default.
• W2990180269 creator A5070498798 @default.
• W2990180269 creator A5070548596 @default.
• W2990180269 creator A5075038951 @default.
• W2990180269 creator A5075681567 @default.
• W2990180269 creator A5077285569 @default.
• W2990180269 creator A5078614053 @default.
• W2990180269 creator A5082660821 @default.
• W2990180269 creator A5083387415 @default.
• W2990180269 creator A5084896635 @default.
• W2990180269 creator A5085204876 @default.
• W2990180269 date "2019-09-28" @default.
• W2990180269 modified "2023-10-16" @default.
• W2990180269 title "Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations" @default.
• W2990180269 doi "https://doi.org/10.1183/13993003.congress-2019.oa2140" @default.
• W2990180269 hasPublicationYear "2019" @default.
• W2990180269 type Work @default.
• W2990180269 sameAs 2990180269 @default.
• W2990180269 citedByCount "2" @default.
• W2990180269 countsByYear W29901802692020 @default.
• W2990180269 countsByYear W29901802692022 @default.
• W2990180269 crossrefType "proceedings-article" @default.
• W2990180269 hasAuthorship W2990180269A5014703126 @default.
• W2990180269 hasAuthorship W2990180269A5024611768 @default.
• W2990180269 hasAuthorship W2990180269A5031799252 @default.
• W2990180269 hasAuthorship W2990180269A5032598604 @default.
• W2990180269 hasAuthorship W2990180269A5034045334 @default.
• W2990180269 hasAuthorship W2990180269A5035168811 @default.
• W2990180269 hasAuthorship W2990180269A5037313446 @default.
• W2990180269 hasAuthorship W2990180269A5038193085 @default.
• W2990180269 hasAuthorship W2990180269A5038839524 @default.
• W2990180269 hasAuthorship W2990180269A5050803363 @default.
• W2990180269 hasAuthorship W2990180269A5051029267 @default.
• W2990180269 hasAuthorship W2990180269A5055981872 @default.
• W2990180269 hasAuthorship W2990180269A5057552882 @default.
• W2990180269 hasAuthorship W2990180269A5062488371 @default.
• W2990180269 hasAuthorship W2990180269A5069155913 @default.
• W2990180269 hasAuthorship W2990180269A5070498798 @default.
• W2990180269 hasAuthorship W2990180269A5070548596 @default.
• W2990180269 hasAuthorship W2990180269A5075038951 @default.
• W2990180269 hasAuthorship W2990180269A5075681567 @default.
• W2990180269 hasAuthorship W2990180269A5077285569 @default.
• W2990180269 hasAuthorship W2990180269A5078614053 @default.
• W2990180269 hasAuthorship W2990180269A5082660821 @default.
• W2990180269 hasAuthorship W2990180269A5083387415 @default.
• W2990180269 hasAuthorship W2990180269A5084896635 @default.
• W2990180269 hasAuthorship W2990180269A5085204876 @default.
• W2990180269 hasConcept C126322002 @default.
• W2990180269 hasConcept C141071460 @default.
• W2990180269 hasConcept C16020263 @default.
• W2990180269 hasConcept C165637977 @default.
• W2990180269 hasConcept C2777714996 @default.
• W2990180269 hasConcept C2778341716 @default.
• W2990180269 hasConcept C2779832356 @default.
• W2990180269 hasConcept C2780171596 @default.
• W2990180269 hasConcept C3018587741 @default.
• W2990180269 hasConcept C71924100 @default.
• W2990180269 hasConcept C90924648 @default.
• W2990180269 hasConceptScore W2990180269C126322002 @default.
• W2990180269 hasConceptScore W2990180269C141071460 @default.
• W2990180269 hasConceptScore W2990180269C16020263 @default.
• W2990180269 hasConceptScore W2990180269C165637977 @default.
• W2990180269 hasConceptScore W2990180269C2777714996 @default.
• W2990180269 hasConceptScore W2990180269C2778341716 @default.
• W2990180269 hasConceptScore W2990180269C2779832356 @default.
• W2990180269 hasConceptScore W2990180269C2780171596 @default.
• W2990180269 hasConceptScore W2990180269C3018587741 @default.
• W2990180269 hasConceptScore W2990180269C71924100 @default.
• W2990180269 hasConceptScore W2990180269C90924648 @default.
• W2990180269 hasLocation W29901802691 @default.
• W2990180269 hasLocation W29901802692 @default.
• W2990180269 hasLocation W29901802693 @default.
• W2990180269 hasOpenAccess W2990180269 @default.
• W2990180269 hasPrimaryLocation W29901802691 @default.
• W2990180269 hasRelatedWork W2343057847 @default.
• W2990180269 hasRelatedWork W2418905634 @default.
• W2990180269 hasRelatedWork W2979280297 @default.
• W2990180269 hasRelatedWork W2980575734 @default.
• W2990180269 hasRelatedWork W2984350958 @default.
• W2990180269 hasRelatedWork W2991063759 @default.
• W2990180269 hasRelatedWork W3009046559 @default.
• W2990180269 hasRelatedWork W3134626940 @default.
• W2990180269 hasRelatedWork W4214608853 @default.
• W2990180269 hasRelatedWork W4367052859 @default.

• next